Keyphrases
Event-free Survival
100%
Improved Outcomes
100%
IKZF1 Deletion
100%
ETV6-RUNX1
66%
Down Syndrome
66%
IKZF1
66%
Media Risk
66%
Prednisone
66%
Overall Survival
50%
Relapse Risk
50%
Cumulative Risk
50%
High Risk
33%
Chemotherapy
16%
Poor Outcome
16%
Anthracyclines
16%
Standard Risk
16%
Minimal Residual Disease
16%
Excellent Outcome
16%
Complete Remission
16%
5-year Survival
16%
Maintenance Therapy
16%
Risk of Death
16%
Historical Controls
16%
High Toxicity
16%
Nineteen
16%
Survival Events
16%
Survival Improvement
16%
Nonrandomized Studies
16%
5-year Outcomes
16%
Prolonged Therapy
16%
Group Standard
16%
Biochemistry, Genetics and Molecular Biology
High Risk Population
100%
Event Free Survival
100%
IKZF1
100%
ETV6
66%
RUNX1
66%
Overall Survival
66%
Down Syndrome
66%
Prednisone
66%
Anthracycline
16%
Neuroscience
IKZF1
100%
Prednisone
80%
Down Syndrome
80%
RUNX1
80%
ETV6
80%
Anthracycline
20%
Pharmacology, Toxicology and Pharmaceutical Science
Event Free Survival
100%
Overall Survival
66%
Prednisone
66%
Down Syndrome
66%
Anthracycline
16%
Chemotherapy
16%
Remission
16%
Minimal Residual Disease
16%
Immunology and Microbiology
Event Free Survival
100%
High Risk Population
100%
Overall Survival
66%
Prednisone
66%